The Productivity of Medical Publication on COVID-19 in the First Half of 2020: A Retrospective Analysis of Articles Available in PubMed

Background The control of the coronavirus disease 2019 (COVID-19) pandemic depends on the profound investigation of the virus biology and its consequences. We aimed to analyze the COVID-19 research productivity of authors representing different countries and associations between the number of articles and COVID-19 spread. Methods We retrieved all articles on COVID-19 indexed in PubMed between 31 December 2019 and 30 June 2020. We identified the countries of individual authors’ affiliations. We performed the R Spearman rank correlation test between the number of articles with at least one author from a country per one million citizens and Human Development Index (HDI), a number of COVID-19 cases and deaths per one million citizens before 1 July 2020. Results Overall, we identified 27,815 articles, including 18,225 original contributions, 2,449 reviews, and 69 meta-analyses on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The highest productivity characterized the authors coming from China (n = 11,519 articles with at least one author), followed by the United States of America (n = 9,666) and Italy (n = 7,261). The number of articles on COVID-19 associated with HDI (Rs = 0.79), the numbers of cases (Rs = 0.47), and deaths (Rs = 0.46) (all p < 0.001). Conclusions Early COVID-19 researches were most often authored by researchers from highly developed countries and those affected by the rapid initial spread of SARS-CoV-2.

[1]  T. Lancet Research and higher education in the time of COVID-19 , 2020, The Lancet.

[2]  The Lancet Research and higher education in the time of COVID-19 , 2020, The Lancet.

[3]  Jay J H Park,et al.  Clinical trials of disease stages in COVID 19: complicated and often misinterpreted , 2020, The Lancet Global Health.

[4]  M. Prudêncio,et al.  Research funding after COVID-19 , 2020, Nature Microbiology.

[5]  M. Fernández-Guarino,et al.  Enanthem in Patients With COVID-19 and Skin Rash. , 2020, JAMA dermatology.

[6]  Yian Yin,et al.  Unequal effects of the COVID-19 pandemic on scientists , 2020, Nature Human Behaviour.

[7]  T. Velavan,et al.  COVID-19 in Africa: between hope and reality , 2020, The Lancet Infectious Diseases.

[8]  D. Operario,et al.  Research with Marginalized Communities: Challenges to Continuity During the COVID-19 Pandemic , 2020, AIDS and Behavior.

[9]  W. Raghupathi,et al.  Healthcare Expenditure and Economic Performance: Insights From the United States Data , 2020, Frontiers in Public Health.

[10]  E. Marbán,et al.  COVID-19 and the Heart , 2020, Circulation research.

[11]  J. Turnbull,et al.  Has Embase replaced MEDLINE since coverage expansion? , 2018, Journal of the Medical Library Association : JMLA.

[12]  F. Farrokhyar,et al.  Impact of research investment on scientific productivity of junior researchers , 2016, Translational behavioral medicine.

[13]  Giulio Cimini,et al.  The Scientific Competitiveness of Nations , 2014, PloS one.